Prenatal Yoga Intervention in Pregnant Women
9 de mayo de 2026 actualizado por: Duygu Özer, PhD, Saglik Bilimleri Universitesi
Effects of a Prenatal Yoga Intervention on Traumatic Childbirth Perception, Self-Perception, and Delivery Preferences in Pregnant Women
The aim of this study is to determine the effects of a prenatal yoga intervention on traumatic childbirth perception, self-perception, and delivery preferences in pregnant women.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Intervención / Tratamiento
Descripción detallada
This study will be conducted with voluntary pregnant women aged 18 years and older, at or beyond the 16th week of gestation, and without a diagnosis of high-risk pregnancy. Participants will be randomly assigned to the intervention and control groups using a computer-generated simple randomization method (https://www.random.org/integers/
) to ensure unbiased allocation. The intervention group will consist of 8-12 participants per group, and the program will be implemented in three separate groups. Participants in the intervention group will receive a prenatal yoga program consisting of eight sessions delivered twice weekly, while the control group will receive routine prenatal care without any additional intervention from the researchers. Data collection instruments will be administered at baseline (pre-test), at the end of the eighth session (post-test), and at a one-month follow-up.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
46
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Duygu Özer, Asst. Prof
- Número de teléfono: +905061291978
- Correo electrónico: duyguozer2016@hotmail.com
Ubicaciones de estudio
-
-
Bartın
-
Bartın, Bartın, Turquía (Türkiye), 74100
- Reclutamiento
- Bartın University
-
Contacto:
- Duygu Özer, Asst. prof
- Número de teléfono: +9 05061291978
- Correo electrónico: duyguozer2016@hotmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Being at or beyond the 16th week of gestation (second trimester or later)
- Being aged 18 years or older
- Having no diagnosis of high-risk pregnancy based on obstetric evaluation
- Having no medical restriction on physical activity or yoga practice as determined by a physician
- Providing written informed consent after being informed about the study
Exclusion Criteria:
- Diagnosis of high-risk pregnancy (e.g., preeclampsia, placenta previa, premature rupture of membranes, risk of preterm birth, or other serious obstetric complications)
- Physician-imposed restriction on physical activity
- Presence of serious systemic conditions that would prevent participation in yoga practice
- Inability to complete the questionnaires reliably due to psychiatric or cognitive conditions
- Declining to participate or not providing informed consent
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental
Prenatal Yoga Program was applied to the intervention group.
|
Participants in the intervention group received a structured prenatal yoga program consisting of eight sessions delivered twice weekly.
Each session lasted approximately 45 minutes and was conducted in accordance with safe prenatal exercise guidelines.
|
|
Sin intervención: Control
Participants in the control group received routine prenatal care only and were not exposed to any structured intervention during the study period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Traumatic Childbirth Perception Scale
Periodo de tiempo: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
The Traumatic Childbirth Perception Scale is a self-report instrument designed to assess perceptions of traumatic childbirth, including physical, emotional, and psychological aspects.
The scale consists of 13 items.
Each item is rated on a scale ranging from 0 to 10, and total scores range from 0 to 130, with higher scores indicating higher levels of perceived traumatic childbirth.
Mean total scores are used to interpret the level of traumatic childbirth perception.
The score ranges are categorized as follows: 0-26 (very low), 27-52 (low), 53-78 (moderate), 79-104 (high), and 105-130 (very high).
|
Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pregnant Women's Self-Perception Scale
Periodo de tiempo: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
The scale consists of 12 items rated on a 4-point Likert scale ranging from 1 (never) to 4 (always).
It comprises two subscales: maternal perception related to pregnancy (7 items) and body perception during pregnancy (5 items).
Higher scores on the maternal perception subscale (range: 7-28) indicate higher levels of positive maternal perception.
In contrast, higher scores on the body perception subscale (range: 5-20) reflect more negative body perception during pregnancy.
|
Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
|
Preferred Mode of Delivery Scale for Pregnant Women
Periodo de tiempo: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
The scale is suitable for women without systemic or psychiatric disorders and who conceived naturally.
It consists of 18 items and three subscales: self-efficacy, normative beliefs, and preferences.
Items are rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Items 6-14 and 16-18 are reverse scored.
The total score is calculated by summing all item responses, and subscale scores can be obtained by summing the corresponding items.
The scale does not have a cut-off point.
Total scores range from 18 to 90, with higher scores indicating a stronger preference for vaginal delivery, as all items are scored in favor of vaginal birth for ease of interpretation.
|
Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
15 de mayo de 2026
Finalización primaria (Estimado)
30 de septiembre de 2026
Finalización del estudio (Estimado)
30 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
2 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
9 de mayo de 2026
Publicado por primera vez (Actual)
14 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
14 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
9 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- BARU-SBF-DO-4
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .